Pulse Biosciences (PLSE) Cash from Operations Growth (1y) (2016 - 2025)
Pulse Biosciences (PLSE) Cash from Operations Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.11 Bn | 120.90 Bn | 1.96 Bn | 48.31% |
| 2 | Becton Dickinson | 44.96 Bn | 44.15 Bn | 2.15 Bn | 428.92% |
| 3 | Alcon | 33.16 Bn | 31.50 Bn | 1.53 Bn | - |
| 4 | Medline | 33.00 Bn | 30.76 Bn | 1.84 Bn | -39.59% |
| 5 | Resmed | 29.51 Bn | 27.85 Bn | 890.98 Mn | -4.24% |
| 6 | West Pharmaceutical Services | 23.50 Bn | 23.06 Bn | 329.20 Mn | -29.98% |
| 7 | Solventum | 14.07 Bn | 13.51 Bn | 1.10 Bn | -751.72% |
| 8 | Cooper Companies | 13.92 Bn | 13.78 Bn | 735.40 Mn | 90.02% |
| 9 | Align Technology | 12.14 Bn | 11.08 Bn | 736.59 Mn | 186.74% |
| 10 | Pulse Biosciences | 2.15 Bn | 2.07 Bn | - | -61.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -61.36% |
| Sep 30, 2025 | -44.49% |
| Jun 30, 2025 | -52.56% |
| Mar 31, 2025 | -38.25% |
| Dec 31, 2024 | -34.83% |
| Sep 30, 2024 | 13.95% |
| Jun 30, 2024 | 8.77% |
| Mar 31, 2024 | -48.86% |
| Dec 31, 2023 | 14.85% |
| Sep 30, 2023 | 1.36% |
| Jun 30, 2023 | 28.23% |
| Mar 31, 2023 | 57.87% |
| Dec 31, 2022 | 37.25% |
| Sep 30, 2022 | 20.36% |
| Jun 30, 2022 | 21.65% |
| Mar 31, 2022 | -33.43% |
| Dec 31, 2021 | -37.16% |
| Sep 30, 2021 | -56.16% |
| Jun 30, 2021 | -106.15% |
| Mar 31, 2021 | -21.46% |